英文名称 |
中文名称 |
CAS |
Rivaroxaban Impurity 8
|
N,N'-二[{(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基]-1,3-恶唑啉-5-基}甲基]苯基-1,2-二酰胺 |
1365267-36-2 |
Rivaroxaban Impurity 9
|
利伐沙班邻苯二甲酰亚胺杂质 |
446292-08-6 |
Nortriptyline Impurity H
|
去甲替林杂质H |
24755-73-5 |
Olaparib Impurity 2
|
奥拉帕利杂质2 |
|
trans-10-Hydroxy Nortriptyline
|
-E-10-羟基去甲替林 |
74853-74-0 |
Rivaroxaban Impurity 6
|
利伐沙班杂质6 |
|
Rivaroxaban Impurity 7
|
利伐沙班杂质7 |
|
Rivaroxaban Metabolite 5
|
利伐沙班代谢物5 |
|
Rivaroxaban Impurity 2
|
利伐沙班杂质2 |
|
Rivaroxaban Impurity L
|
利伐沙班杂质L |
|
Rivaroxaban Metabolite 8
|
利伐沙班代谢物8 |
|
Rivaroxaban Metabolite 9
|
利伐沙班代谢物9 |
|
Rivaroxaban Impurity 3
|
利伐沙班杂质3 |
|
Rivaroxaban Impurity 5
|
利伐沙班杂质5 |
|
N-Didesmethyl Olopatadine HCl
|
N-DidesMethyl Olopatadine HCl |
113835-94-2 |
Olopatadine Carbaldehyde HCl
|
|
|
Ophthazin Impurity 2
|
双肼酞嗪杂质2 |
1044569-46-1 |
Ophthazin Impurity 1
|
双肼酞嗪杂质1 |
|
Rivaroxaban Impurity 20
|
N-甲基邻苯二甲酰亚胺 |
550-44-7 |
Olopatadine N-Oxide
|
奥洛他定N氧化物 |
203188-31-2 |
Ophthazin Sulfate
|
硫酸双肼屈嗪 |
7327-87-9 |
Rivaroxaban Related Compound (5-Chloro-2-Thiophenecarboxylic Acid N-Methylamide)
|
5-氯噻吩-2-甲酰甲胺 |
97799-98-9 |
Rivaroxaban Related Compound
|
2-氯噻吩-5-甲酸 |
24065-33-6 |
Rivaroxaban Impurity G
|
利伐沙班杂质G |
721401-53-2 |
Rivaroxaban Impurity 15
|
利伐沙班乙酰草酰胺杂质 |
931204-39-6 |
Rivaroxaban Impurity 29
|
Rivaroxaban Impurity 29 |
|
Rivaroxaban Impurity 28
|
利伐沙班杂质28 |
2489689-18-9 |
Rivaroxaban Impurity 1
|
利伐沙班杂质1 |
|
Rivaroxaban Impurity 23
|
利伐沙班杂质23 |
|
Rivaroxaban Impurity 14
|
利伐沙班相关化合物D |
1365267-35-1 |
Rivaroxaban Impurity 22
|
利伐沙班杂质22 |
|
Rivaroxaban Impurity 25
|
利伐沙班杂质25 |
|
Rivaroxaban Impurity 27
|
利伐沙班杂质27 |
1369969-44-7 |
Rivaroxaban Impurity 26
|
Rivaroxaban Impurity 26 |
1838133-00-8 |
Rivaroxaban Impurity 21
|
利伐沙班杂质 21 |
1328136-38-4 |
Olopatadine Acetaldehyde
|
奥洛他定醛基杂质 |
1376615-97-2 |
6-beta-Hydroxy Norethindrone Acetate (Norethindrone Acetate Impurity F)
|
6-Β羟基醋酸炔诺酮 |
6856-27-5 |
Norethindrone Impurity 7
|
|
|
Norethindrone 3-isopropyldienol Ether
|
|
|
6-beta-Hydroxy Norethindrone (Norethindrone Impurity H)
|
6-Β羟基炔诺酮 |
51724-44-8 |
Norethindrone Acetate Dimer
|
|
|
Delta 5(10)-Norethindrone Acetate
|
Δ5(10)醋酸炔诺酮 |
19637-28-6 |
Delta-5(6)-Norethindrone (Norethindrone Impurity C)
|
Δ-5(6)-NORETHINDRONE |
22933-71-7 |
6-Keto Norethindrone Acetate (Norethindrone Impurity G)
|
6-酮基醋酸炔诺酮 |
438244-27-0 |
Norethindrone Impurity 2
|
DIETHINYLESTRADIENOL |
79727-03-0 |
Norethindrone Acetate 3-Isopropylenol Ether
|
Norethindrone Acetate 3-Isopropylenol Ether |
|
Norethindrone EP Impurity F
|
炔诺酮杂质6 |
96487-85-3 |
Delta-5(6)-Norethindrone Acetate (Impurity C)
|
醋酸炔诺酮杂质C |
1175129-26-6 |
6-Beta-Hydroxy-19-Norandrostenedione
|
炔诺酮杂质23(6-Β-羟基-19-去甲雄烯二酮) |
5949-49-5 |
Norethindrone Related Compound
|
17-ethynyl-4-estrene-3,17-diol-3-acetate-17-(3'-acetoxy-2'-butenoate) |
142154-46-9 |
17,17-bis(17-hydroxy-18a-homoestr-4-ene-3-one
|
17,17-双(17-羟基-18A-HOMOESTR-4-ENE-3-ONE |
|
3alfa,5-beta-Tetrahydro Levonorgestrel
|
3Α,5-Β-甲氢左炔诺孕酮 |
|
Norgestrel
|
炔诺孕酮 |
6533-00-2 |
Rivaroxaban Dimer Impurity
|
|
|
Rivaroxaban Related Compound (Ethyl 4-(3-Oxomorpholino)-Phenylcarbamate)
|
利伐沙班中间体2 |
1327778-39-1 |
Rivaroxaban Impurity 11
|
利伐沙班杂质 11 |
1411775-06-8 |
Rivaroxaban Impurity 10
|
|
|
Rivaroxaban Impurity 13
|
利伐沙班代谢物M1 |
1160169-98-1 |
Rivaroxaban Impurity 12
|
利伐沙班杂质 12 |
936232-22-3 |
Alpha-hydroxy Olopatadine Sodium Salt ( Olopatadine Impurity A)
|
阿尔法羟基奥洛他定钠盐(奥洛他定杂质) |
|
N-Desmethyl Olopatadine HCl
|
N-去甲盐酸奥洛他定 |
|
Rivaroxaban Impurity 4
|
利伐沙班杂质H |
1429334-00-8 |
Carboxylate Ion of Nystatin
|
|
|
Norethisterone Impurity A
|
|
|
Norgestrel Sulfate Sodium Salt
|
诺格瑞硫酸盐 |
|
Nortriptyline N-Glucuronide
|
去甲替林 N-葡糖苷酸 |
|
Norethindrone Impurity E
|
炔诺酮杂质E |
66964-58-7 |
Nortriptyline Impurity G
|
去甲替林N-氨基甲酸乙酯 |
16234-88-1 |
Norethindrone Impurity O
|
|
|
Nuzhenide Impurity 1
|
女贞子甙杂质1 |
|
3-Methyl-2-quinoxalinecarboxylic acid
|
3-甲基-喹啉-2-甲酸 |
74003-63-7 |
Octaverine Hydrochloride
|
辛凡林 |
6775-26-4 |
Olaparib Impurity 1
|
|
|
6-alpha-Hydroxy Norethindrone Acetate
|
6-Α羟基醋酸炔诺酮 |
6856-28-6 |
6β,17-Norethindrone Diacetate
|
|
|
6,10-di-Hydroxy Norethindrone Acetate
|
6,10-二羟基醋酸炔诺酮 |
|
6,7-Didehydro Norethindrone
|
6, 7-二脱氢炔诺酮 |
31528-46-8 |
6,7-Dehydro Norethindrone Acetate
|
17-羟基-19-去甲-17ALPHA-孕甾-4,6-二烯-20-炔-3-酮乙酸酯 |
106765-04-2 |
Rivaroxaban Impurity 19
|
利伐沙班杂质 19 |
|
Rivaroxaban Impurity 24
|
利伐沙班杂质24 |
|
Rivaroxaban Impurity 16
|
利伐沙班杂质 16 |
|
(S,R,S,S) Orlistat
|
(S,R,S,S) -奥利司他 |
111466-63-8 |
(S,S,R,R)-Orlistat
|
(S,S,R,R)-奥利司他 |
111466-62-7 |
Orlistat Related Compound [(S)-3-Hexyl-5,6-dihydro-6-undecyl-2H-pyran-2-one
|
奥利司他二氢吡喃酮杂质 |
130676-64-1 |
Rivaroxaban Related Compound (R-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl)phenyl-Morpholin-3-One HCl)
|
利伐沙班相关化合物 |
1429311-47-6 |
Rivaroxaban O-Carboxy Benzamide Impurity
|
利伐沙班杂质 34 |
|
Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid)
|
奥利司他开环杂质(2S,3R,5S)异构体 |
130793-28-1 |
Orlistat Impurity 3
|
奥利司他杂质3 |
|
N-Deformyl-N-benzyloxycarbonyl Orlistat
|
N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT |
108051-94-1 |
5-Methyl-L-Norleucine Orlistat Analogue
|
奥利司类似物 |
1356847-30-7 |
Orlistat degradation product sodium salt
|
|
|
Orlistat Related Compound D
|
奥利司他相关化合物D |
130793-27-0 |
Orlistat Impurity 2
|
奥利司他杂质2 |
130676-63-0 |
Orlistat Impurity M1
|
奥利司他杂质M1 |
130676-66-3 |
Orlistat USP Related Compound E
|
N-甲酰基-L-异亮氨酸 (1S)-1-[[(2S,3S)-3-己基-4-氧代-2-氧杂环丁基]甲基]十二烷基酯 |
1072902-75-0 |
Orlistat Dimer Impurity
|
奥利司他二聚物杂质 |
881900-54-5 |
N-Deformyl-N-pivaloyl Orlistat
|
N-DEFORMYL-N-PIVALOYL ORLISTAT |
1356017-35-0 |
(R,S,S,S)-Orlistat
|
(R,S,S,S)-奥利司他 |
104872-28-8 |
(S,R,R,R)-Orlistat
|
(S,R,R,R) -奥利司他 |
111466-61-6 |
Octyl Orlistat
|
奥利司他杂质8(奥利司他辛基) |
1243011-56-4 |